Stock Updates

Is this Large Market Cap Stock target price reasonable for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)?

The company in question is, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) currently with a stock price of 93.61 (0.43% today). The market cap for Vertex Pharmaceuticals Incorporated is 22528.86, and is in the sector Healthcare, and Biotechnology industry. The target price for Vertex Pharmaceuticals Incorporated is 108.95. Currently Vertex Pharmaceuticals Incorporated is trading with a P/E of *TBA, and a forward P/E of 29.39. Average volume for Vertex Pharmaceuticals Incorporated is 1665.62 and so far today it is 496140.

Performance in the last year for Vertex Pharmaceuticals Incorporated has been -28.86%. For EPS growth, Vertex Pharmaceuticals Incorporated has seen a growth of 26.50%, and is looking to grow in the next year to 208.76%. More long term stats show that EPS growth has been 9.30% over the last five years and could be 51.20% for the next five years. Vertex Pharmaceuticals Incorporated has seen sales growth quarter over quarter at 187.40%, with EPS growth quarter over quarter at 79.40%. The 20-day simple moving average is 6.20%, with the 200-day simple moving average coming to -4.90%.

Since the IPO date for Vertex Pharmaceuticals Incorporated on the 7/24/1991, Vertex Pharmaceuticals Incorporated has seen performance year to date to be -25.92%. With Vertex Pharmaceuticals Incorporated trading at 93.61, the dividend yield is *TBA, and the EPS is -1.65.

So could Vertex Pharmaceuticals Incorporated, be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 17.44 and the P/B is at 23.72. The P/cash is 21.97, with P/free cash flow at *TBA.

Vertex Pharmaceuticals Incorporated ability to deal with debt shows that the current ratio is 2.5, and the quick ratio is 2.4. This is with long term debt/equity at 0.69, and total debt/equity at 0.86.

In terms of margins, Vertex Pharmaceuticals Incorporated has a gross margin of 87.80%, an operating margin of -23.90% and a profit margin of -30.90%.Payout ratio for Vertex Pharmaceuticals Incorporated is *TBA. Return on assets come to -16.30% with return on investment coming to -28.20%.

Insider ownership for Vertex Pharmaceuticals Incorporated, is at 0.50% and institutional ownership comes to 97.00%. Outstanding shares are at 241.7. While shares float is 241.7. The float short is currently 2.80%, and short ratio is 4.06.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment